|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Double-Blind, Placebo-Controlled Investigation of Amantadine for Weight Loss in Subjects who Gained Weight with Olanzapine |
Investigación a Doble Ciego Controlada con Placebo sobre Amantadina para la Pérdida de Peso en los Pacientes que lo Aumentaron con Olanzapina |
||
|
amantadina, olanzapina, aumento de peso |
amantadine, olanzapine, weight gaining |
||
|
Graham KA, Gu H, Lieberman JA, Harp JB, Perkins DO |
K A Graham, Department of Psychiatry, UNC Neurosciences Hospital NC 27599 Chapel Hill EE.UU |
||
|
National Institute of Health , Eli Lilly and Co. |
Los autores no manifiestan conflictos de interés |
||
|
Department of Psychiatry, UNC Neurosciences Hospital |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|